Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Peripheral interventions industry 3600 synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Application trends
2.6 End-use trends
Chapter 3 Peripheral Interventions Industry Insights
3.1 Impact on COVID-19
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Patent landscape
3.6 Pipeline landscape
3.7 Industry impact forces
3.7.1 Growth drivers
3.7.1.1 Increasing prevalence of cardiovascular disorders
3.7.1.2 Rising adoption of minimally invasive procedures
3.7.1.3 Technological advancements in peripheral intervention devices
3.7.1.4 Growing number of catheterization laboratories in emerging markets
3.7.2 Industry pitfalls & challenges
3.7.2.1 Lack of awareness regarding peripheral artery disease
3.7.2.2 High set-up cost associated with peripheral intervention
3.7.2.3 Increasing risk of post-procedural complications
3.8 Growth potential analysis
3.8.1 By product
3.8.2 By application
3.8.3 By end-use
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Abbott Laboratories
4.1.2 Medtronic Plc.
4.1.3 Boston Scientific Corporation
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Peripheral Interventions Market Estimates and Forecast, By Product (Revenue)
5.1 Key trends, by product
5.2 Catheters
5.3 Sheath
5.4 Stents
5.4.1 Bare metal stents
5.4.2 Drug-eluting stents
5.4.3 Others
5.5 Guide wires
5.6 Atherectomy devices
5.7 Embolic devices
5.8 Thrombectomy devices
5.9 IVC filters
5.10 Others
Chapter 6 Peripheral Interventions Market Estimates and Forecast, By Application (Revenue)
6.1 Key trends, by application
6.2 Peripheral artery disease
6.3 Venous thromboembolism
6.4 Others
Chapter 7 Peripheral Interventions Market Estimates and Forecast, By End-use, (Revenue)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Catheterization laboratories
7.4 Ambulatory surgical centers
7.5 Others
Chapter 8 Peripheral Interventions Market Estimates and Forecast, By Region (Revenue)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Switzerland
8.3.7 The Netherlands
8.3.8 Denmark
8.3.9 Poland
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Vietnam
8.4.8 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AngioDynamics Inc.
9.3 Biotronik SE & Co. KG
9.4 Boston Scientific Corporation
9.5 Cook Medical
9.6 W. L. Gore & Associates Inc
9.7 Teleflex Incorporated
9.8 Medtronic
9.9 Becton Dickinson and Company (C.R. Bard)
9.10 Cardinal Health Inc
9.11 B. Braun Melsungen AG
9.12 Terumo Corporation
